Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Factors in Childhood B-ALL Relapse
NCT02618109Phase 4Terminated
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Jan 2016
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 4, open-label trial (2 arms), sponsored by Centre Hospitalier Universitaire d'Angers. Primary endpoint: Proportions of Treg (CD4+,CD25+, Foxp3+) and deficient natural killer (NK) cells (CD3-,CD56+,NKp30-). Started Jan 2016; status: terminated.
Beyond the preview
Go deeper on NCT02618109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02618109.